Gastric cancer is the fifth leading cause of cancer-related deaths globally, while oesophageal cancer is the sixth ...

AbbVie has announced that it will be acquiring Aliada Therapeutics for $1.4bn, marking a notable boost to its neuroscience ...

Inizio Medical has announced the appointment of Patrick Giordani as senior vice president, artificial intelligence (AI) solutions architect.

Merck & Co’s – known as MSD outside the US and Canada – Keytruda (pembrolizumab) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat resectable non-small cell ...

Merck & Co – known as MSD outside the US and Canada – has acquired Yale University oncology spinout Modifi Biosciences in a deal worth $1.3bn. The agreement gives Merck access to preclinical compounds ...

Novartis’ Kisqali (ribociclib) has been recommended by the European Medicines Agency’s human medicines committee to reduce the risk of recurrence in early breast cancer patients. The Committee for ...

AstraZeneca’s (AZ) Voydeya (danicopan) has been recommended by the National Institute for Health and Care Excellence (NICE) as an add-on therapy for adults with the rare blood disorder paroxysmal ...

Johnson & Johnson (J&J) has announced that a subcutaneous (SC) formulation of Darzalex (daratumumab) has been approved by the European Commission (EC) as part of a combination treatment for newly ...

Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what ...

The pharmaceutical industry is undergoing a transformative shift, recognising the critical importance of diversity in clinical trials. Ensuring that research findings are applicable and beneficial to ...

Novo Nordisk’s Alhemo (concizumab) has been recommended by the European Medicines Agency’s human medicines committee to prevent bleeding in haemophilia patients aged 12 years or older. If approved, ...